News
Janssen's Darzalex has received approval in the EU in combination with bortezomib, melphalan and prednisone (VMP) as a frontline therapy in the...
The US multinational Pfizer has said that Brexit will cost the company $100 million in spend associated with the transference of product and...
Antimicrobial resistance (AMR) could be effectively combatted by giving people a combination of antibiotic drugs that are no longer effective on...
The US Food and Drug Administration (FDA) have rejected American pharma firm Sunovion’s application to market dasotraline for the treatment of...
A group of Dutch doctors and health advocates are taking action against the Italian pharmaceutical firm Leadiant Biosciences who have increased the...
WIth full-length features on drug safety and on the latest innovations in the diagnosis of cancer and the discovery of new drugs to fight the disease...
A team of scientists at the Institute of Cancer Research in London and the University of Edinburgh have developed an artificial intelligence that...
The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that the uncertainty...
Novartis expands operations after Kymriah's EU approval, UK Government fails to reassure with "no deal" Brexit guidance, and homepathic medicines...
